SNIFF - Combo INI+EMPA Trial

Conditions:   Mild Cognitive Impairment;   Cognitive Impairment;   Alzheimer Disease Interventions:   Drug: Insulin (Humulin® R U-100);   Drug: Empagliflozin 10 MG;   Device: Aptar Pharma CPS Intranasal Delivery Device;   Drug: Placebo (Insulin Diluent);   Drug: Placebo (Capsules) Sponsor:   Wake Forest University Health Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials